These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11758138)

  • 41. Prophylactic and early targeted treatment of patent ductus arteriosus.
    Wyllie JP; Gupta S
    Semin Fetal Neonatal Med; 2018 Aug; 23(4):250-254. PubMed ID: 29571706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does treatment of patent ductus arteriosus with cyclooxygenase inhibitors affect neonatal regional tissue oxygenation?
    Bhatt M; Petrova A; Mehta R
    Pediatr Cardiol; 2012 Dec; 33(8):1307-14. PubMed ID: 22466710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and safety of treatments used for the management of patent ductus arteriosus (PDA) in preterm infants: a protocol for a systematic review and network meta-analysis.
    Mitra S; Florez ID; Tamayo ME; Aune D; Mbuagbaw L; Veroniki AA; Thabane L
    BMJ Open; 2016 Jul; 6(7):e011271. PubMed ID: 27456327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of PDA Treatment in Preterm Neonates Who Had Received Prophylactic Indomethacin.
    Louis D; ElSayed YN; Ojah C; Alvaro R; Shah PS; Dunn M;
    Am J Perinatol; 2018 Apr; 35(5):509-514. PubMed ID: 29183097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.
    Sung SI; Chang YS; Chun JY; Yoon SA; Yoo HS; Ahn SY; Park WS
    J Pediatr; 2016 Oct; 177():66-71.e1. PubMed ID: 27453374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH; Yang SN; Chen HL; Tseng HI; Dai ZK; Wu JR
    J Pediatr; 2010 Jul; 157(1):79-84. PubMed ID: 20227723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of patent ductus arteriosus with ibuprofen.
    Van Overmeire B; Follens I; Hartmann S; Creten WL; Van Acker KJ
    Arch Dis Child Fetal Neonatal Ed; 1997 May; 76(3):F179-84. PubMed ID: 9175948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patent ductus arteriosus in preterm infants.
    Sasi A; Deorari A
    Indian Pediatr; 2011 Apr; 48(4):301-8. PubMed ID: 21532100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
    Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
    Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.
    Cooke L; Steer P; Woodgate P
    Cochrane Database Syst Rev; 2003; 2003(2):CD003745. PubMed ID: 12804488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ibubrofen in the treatment of patent ductus arteriosus in preterm infants: what we know, what we still do not know.
    Mercanti I; Ligi I; Boubred F; Grandvuillemin I; Buffat C; Fayol L; Millet V; Simeoni U
    Curr Pharm Des; 2012; 18(21):3007-18. PubMed ID: 22564295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
    Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
    Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants.
    De Carolis MP; Romagnoli C; Polimeni V; Piersigilli F; Zecca E; Papacci P; Delogu AB; Tortorolo G
    Eur J Pediatr; 2000 May; 159(5):364-8. PubMed ID: 10834523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.
    Clyman RI
    Semin Perinatol; 2013 Apr; 37(2):102-7. PubMed ID: 23582964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital variation in medical and surgical treatment of patent ductus arteriosus.
    Lee HC; Durand DJ; Danielsen B; Dueñas GV; Powers RJ
    Am J Perinatol; 2015 Mar; 32(4):379-86. PubMed ID: 25241108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2011 Jul; (7):CD004213. PubMed ID: 21735396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The importance of echocardiography and an individual approach to patent ductus arteriosus treatment in extremely preterm infants.
    Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
    Neonatology; 2015; 107(4):257. PubMed ID: 25720362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.